DIAZEPAM-BINDING INHIBITOR
Diazepam-Binding Inhibitor: A Novel Target for Treatment of Anxiety Disorders Anxiety disorders are a common mental illness affecting millions of people around the world. Current pharmacological treatments for anxiety often target serotonin (5-HT) and/or gamma-aminobutyric acid (GABA) receptors. However, these medications can cause significant side effects, including sedation, addiction, and tolerance. Thus, there is a …